Abbvie Inc (ABBV) Ordinary Shares USD 0.01

Sell:$212.31Buy:$212.43Price increased$1.01 (0.48%)

Prices delayed by at least 15 minutes
Sell:$212.31
Buy:$212.43
Change:Price increased$1.01 (0.48%)
Deal now
Prices delayed by at least 15 minutes
Sell:$212.31
Buy:$212.43
Change:Price increased$1.01 (0.48%)
Prices delayed by at least 15 minutes
Deal now

Key metrics

Open$209.48
Previous close$211.59
Market cap$365.02bn
P/E ratio37.79
Volume1,995,287
Dividend yield3.27%
EMS-

Company information

AbbVie Inc. is a global, diversified research-based biopharmaceutical company. It is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio ...

  • LocationUnited States
  • SectorHealthcare
  • IndustryBiotechnology & Drugs
  • CurrencyUSD
  • Shares in issue1.84bn
Dates and announcementsDirector deals

Earnings and financials

Take a closer look at this company’s financial statements and dividend information.

Dividends

  • Dividend per share$1.73
  • Ex-dividend date16 January 2026
  • Payment date17 February 2026

Costs and Charges

Find out how much you might pay in costs and charges if you choose this investment.

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete and accepts no responsibility for how it may be used. TradingView Lightweight Charts™ Copyright (c) 2026 TradingView, Inc. https://www.tradingview.com/.